Showing results (131-140 of 2,132) with videos related to
Sort By:
Pageof 214
Biopharmaceutics & Drug Disposition|September 4, 2018
The role of organic anion-transporting polypeptides and formulation in the clearance and distribution of a novel Nav 1.7 channel blockerAndy Pike, Neil J Flanagan, R Ian Storer, et al.Biopharmaceutics & Drug Disposition|March 24, 2022
Nanocrystal solid dispersion of fuzapladib free acid with improved oral bioavailabilityKohei Yamada, Yuto Hayashi, Kenta Sasaki, et al.Biopharmaceutics & Drug Disposition|February 27, 2022
Population pharmacokinetics of tacrolimus in Chinese adult liver transplant patientsFei Teng, Weiyue Zhang, Wei Wang, et al.Biopharmaceutics & Drug Disposition|August 12, 2018
Metabolism of steroids by cytochrome P450 2C9 variantsTomohide Uno, Ryosuke Nakano, Risa Kitagawa, et al.Biopharmaceutics & Drug Disposition|December 14, 1999
Pharmacokinetic interactions between HIV-protease inhibitors in ratsH Yamaji, Y Matsumura, Y Yoshikawa, et al.Biopharmaceutics & Drug Disposition|December 14, 1999
Mechanism of the uricosuric action of E3040, a drug used to treat inflammatory bowel disease II: study using DBA/2N miceH Yamada, H Kotaki, H Furitsu, et al.Biopharmaceutics & Drug Disposition|March 4, 2000
Plasma protein binding of celecoxib in mice, rat, rabbit, dog and humanS K Paulson, T A Kaprak, C J Gresk, et al.Biopharmaceutics & Drug Disposition|August 10, 1999
Renal handling of biphosphonate alendronate in ratsI Kino, Y Kato, J H Lin, et al.Biopharmaceutics & Drug Disposition|April 17, 1999
Contribution of P-glycoprotein to bunitrolol efflux across blood-brain barrierJ Matsuzaki, C Yamamoto, T Miyama, et al.Biopharmaceutics & Drug Disposition|April 17, 1999
Pharmacokinetic-pharmacodynamic analysis of the arrhythmogenic potency of a novel antiallergic agent, ebastine, in ratsH Ohtani, H Sato, T Iga, et al.Pageof 214